Reuters: Regulatory News: UPDATE 1-Auxilium penile curvature drug meets study goal

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

UPDATE 1-Auxilium penile curvature drug meets study goal Jun 4th 2012, 12:05 Mon Jun 4, 2012 8:05am EDT June 4 (Reuters) - Auxilium Pharmaceuticals Inc said its drug to treat penile curvature was better than a dummy drug in a late-stage study. The drug Xiaflex, which is already marketed as a treatment for tightening of hand muscles from the accumulation of a type of protein, reduced curvature of the penis by 37.6 percent among men suffering from Peyronie's Disease. Peyronie's Disease is caused by the accumulation of the protein collagen. The drug is marketed in Europe for the hand-disease by partner Pfizer Inc. The specialty pharmaceutical company said the drug was well tolerated in the study, and it plans to file for marketing approval of the drug by the end of the year. Shares of the Malvern, Pennsylvania-based company, which have lost about 6 percent of their value in the last three months, jumped 20 percent before the bell. The closed at $18.85 on Friday on the Nasdaq.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions